Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01943500 · ClinicalTrials.gov registry record
Collection of Blood Specimens for Circulating Tumor Cell Analysis
A clinical trial of Breast Cancer and Prostate Cancer, sponsored by Viatar.
- Completed
- Registry status
- 14
- Enrollment target
- 1
- Study location
NCT01943500: Completed study of Breast Cancer and Prostate Cancer, sponsored by Viatar.
NCT01943500 is a study of Breast Cancer and Prostate Cancer that has completed, run by Viatar. The registered enrollment target is 14 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01943500, a study of Breast Cancer and Prostate Cancer, has completed, sponsored by Viatar.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Objective: To test the sensitivity of a proprietary novel filtration device designed to capture and concentrate circulating tumor cells (CTCs).
Conditions Studied
Study Locations (1)
Massachusetts
- Commonwealth Hematology-Oncology, P.C. - Lawrence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-09-30 |
| Est. Completion | 2016-08-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01943500
The ClinicalTrials.gov registry entry for NCT01943500 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The listed sponsor is Viatar, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01943500 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01943500 about?
NCT01943500 is a clinical study titled "Collection of Blood Specimens for Circulating Tumor Cell Analysis". Objective: To test the sensitivity of a proprietary novel filtration device designed to capture and concentrate circulating tumor cells (CTCs).
What is the current status of trial NCT01943500?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2013-09-30. Estimated completion is 2016-08-26.
What conditions does trial NCT01943500 study?
This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Colorectal Cancer.
Who is sponsoring clinical trial NCT01943500?
This trial is sponsored by Viatar, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01943500 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.